Results 201 to 210 of about 89,996 (262)

Reprogramming the diseased liver: antioxidant-engineered mRNA nanoparticles as microenvironment modulators in MAFLD. [PDF]

Immunometabolism (Cobham)
Ghiringhelli M, Zangi L.
europepmc   +1 more source

Efficacy and safety of endoscopic sleeve gastroplasty for patients with metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and trial sequential meta-analysis. [PDF]

Syst Rev
Sun SP, Chen C, Min H.
europepmc   +1 more source

Amino Acids-Potential Biomarkers of Histological Features for MASLD in Pediatric Obesity. [PDF]

Int J Mol Sci
Zamosteanu D, Filip N, Lozneanu L, Giusca SE, Badulescu OV, Pertea M, Filip A, Ungureanu C, Morosan E, Cojocaru E.   +9 more
europepmc   +1 more source

Semaglutide and Resmetirom in Patients With Metabolic Dysfunction‐Associated Steatohepatitis and Fibrosis: An Exploratory Indirect Comparison

Diabetes, Obesity and Metabolism, EarlyView.
Alessandro Mantovani, Giovanni Targher
wiley   +1 more source

Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

Liver Int
Palomurto S, Flam E, Kaminska D, Virtanen KA, Kärjä V, Käkelä P, Pajukanta P, Eberlé D, Haas JT, Raverdy V, Caiazzo R, Pattou F, Staels B, Pihlajamäki J, Männistö V.   +14 more
europepmc   +1 more source

Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASH. [PDF]

Hepatol Commun
Gee MFW, Fonstad R, De Vol EB, De Vol EB, Brown C, Feld JJ, Patel K, Sanyal AJ.   +7 more
europepmc   +1 more source

Rice Bran Attenuates Liver Fibrosis Caused by Vitamin E Deficiency in the Pre-Aging Stage. [PDF]

Yonago Acta Med
Takahashi Y, Kato Y, Horikoshi Y, Hanaki T, Ueki M, Nakaso K.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Nonalcoholic Steatohepatitis

Seminars in Liver Disease, 2004
Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined aggregate of disorders related to obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia.
Brian P, Mulhall, Zobair M, Younossi
exaly   +8 more sources

Etiopathogenesis of Nonalcoholic Steatohepatitis

Seminars in Liver Disease, 2001
The definable causes of nonalcoholic steatohepatitis (NASH) include jejunoileal bypass surgery (JIB), other causes of rapid and profound weight loss in obese subjects, total parenteral nutrition, drugs, industrial toxins, copper toxicity, and disorders characterized by extreme insulin resistance.
Shivakumar Chitturi, G C Farrell
exaly   +3 more sources